baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Akari Therapeutics Plc/ US00972G2075 /

7/26/2024 7:00:23 PM	Chg. +0.32	Volume	Bid-	Ask-	High	Low
4.24USD	+8.16%	300 Turnover: 1,212	-Bid Size: -	-Ask Size: -	4.24	3.94

GlobeNewswire 6/5 Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholde...

GlobeNewswire 6/4 Akari Therapeutics Secures $7.6 Million in Upsized Financing Round

GlobeNewswire 5/16 Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights

GlobeNewswire 5/1 Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics

GlobeNewswire 5/1 Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merge...

GlobeNewswire 4/15 Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024

GlobeNewswire 4/1 Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights

GlobeNewswire 3/15 SHAREHOLDER ALERT: The M&A Class Action Launches Investigation of the Merger – SDPI, MINM, SCX, AKTX

GlobeNewswire 3/15 SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVK, MINM, SDPI, AKTX

GlobeNewswire 3/9 INVESTIGATION UPDATE: Halper Sadeh LLC Investigates IGT, AKTX, SDPI, VIVK

GlobeNewswire 3/8 Kuehn Law Encourages VIVK, HES, SDPI, and AKTX Investors to Contact Law Firm

GlobeNewswire 3/5 Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expande...

GlobeNewswire 1/2 Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Pla...

GlobeNewswire 12/14/2023 Akari Therapeutics to Present at Biotech Showcase 2024

GlobeNewswire 12/1/2023 Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of ...

GlobeNewswire 11/16/2023 Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomaco...

GlobeNewswire 11/6/2023 Akari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a...

GlobeNewswire 10/4/2023 Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now

GlobeNewswire 10/3/2023 Presenting on the Emerging Growth Conference 63 Day 1 on October 4 Register Now

GlobeNewswire 9/29/2023 Akari Therapeutics Reports First Half 2023 Financial Results and Highlights

GlobeNewswire 9/27/2023 Akari Therapeutics to Present at Emerging Growth Conference

GlobeNewswire 9/21/2023 Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Pla...

GlobeNewswire 9/19/2023 Akari Therapeutics to Host Key Opinion Leader Webinar on Hematopoietic Stem Cell Transplant-Related ...

Akari Therapeutics Plc/ US00972G2075 /

If you wish to receive reply to your feedback, please provide your email address.